Relationship of sFas with metabolic risk factors and their clusters

Akiko Tamakoshi, Koji Suzuki, Yingsong Lin, Yoshinori Ito, Kiyoko Yagyu, Shogo Kikuchi, Yoshiyuki Watanabe, Yutaka Inaba, Kazuo Tajima, Kei Nakachi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Metabolic risk factors are known to cause atherosclerosis through inflammation. In the process of inflammation, soluble Fas (sFas) may interfere with the apoptotic pathway and contribute to dysregulated inflammation. Recent studies suggest sFas as a marker of inflammation in patients with cardiovascular diseases. However, whether a relationship exists between sFas levels and metabolic risk factors among healthy subjects remains unclear. Materials and methods We measured the serum sFas levels of 876 subjects selected as controls for a nested case-control study within the JACC Study. The adjusted means of the sFas levels were compared according to the presence of overweight/obesity, hypertension, hyperlipidaemia, diabetes and their clusters. Results sFas level was significantly associated with overweight/obesity (2·42 ng mL-1 in overweight/obese men and 2·19 in others) and hyperlipidaemia (2·34 ng mL-1 in men with hyperlipidaemia and 2·19 in others) among men, though not with hypertension or diabetes. Moreover, a clear association between sFas levels and the cluster number of metabolic risk factors was observed independently with age, smoking and drinking(2·39, 2·28, 2·24 and 2·11 ng dL-1 in men with three to four, two, one and none of the four metabolic risk factors respectively). However, among women, clear associations were not observed between sFas levels and the four metabolic risk factors or their clustering. Conclusions Serum sFas levels appear to be associated with overweight/obesity, hyperlipidaemia and clusters of metabolic risk factors among men, suggesting that sFas may elevate to down-regulate increased apoptosis in atherogenesis processes.

Original languageEnglish
Pages (from-to)527-533
Number of pages7
JournalEuropean Journal of Clinical Investigation
Volume40
Issue number6
DOIs
Publication statusPublished - 01-06-2010

Fingerprint

Hyperlipidemias
Inflammation
Obesity
Medical problems
Atherosclerosis
Hypertension
Serum
Drinking
Cluster Analysis
Case-Control Studies
Healthy Volunteers
Cardiovascular Diseases
Down-Regulation
Smoking
Apoptosis

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Clinical Biochemistry

Cite this

Tamakoshi, Akiko ; Suzuki, Koji ; Lin, Yingsong ; Ito, Yoshinori ; Yagyu, Kiyoko ; Kikuchi, Shogo ; Watanabe, Yoshiyuki ; Inaba, Yutaka ; Tajima, Kazuo ; Nakachi, Kei. / Relationship of sFas with metabolic risk factors and their clusters. In: European Journal of Clinical Investigation. 2010 ; Vol. 40, No. 6. pp. 527-533.
@article{9b9958d6498d4a69b095341d6ddf50ed,
title = "Relationship of sFas with metabolic risk factors and their clusters",
abstract = "Background: Metabolic risk factors are known to cause atherosclerosis through inflammation. In the process of inflammation, soluble Fas (sFas) may interfere with the apoptotic pathway and contribute to dysregulated inflammation. Recent studies suggest sFas as a marker of inflammation in patients with cardiovascular diseases. However, whether a relationship exists between sFas levels and metabolic risk factors among healthy subjects remains unclear. Materials and methods We measured the serum sFas levels of 876 subjects selected as controls for a nested case-control study within the JACC Study. The adjusted means of the sFas levels were compared according to the presence of overweight/obesity, hypertension, hyperlipidaemia, diabetes and their clusters. Results sFas level was significantly associated with overweight/obesity (2·42 ng mL-1 in overweight/obese men and 2·19 in others) and hyperlipidaemia (2·34 ng mL-1 in men with hyperlipidaemia and 2·19 in others) among men, though not with hypertension or diabetes. Moreover, a clear association between sFas levels and the cluster number of metabolic risk factors was observed independently with age, smoking and drinking(2·39, 2·28, 2·24 and 2·11 ng dL-1 in men with three to four, two, one and none of the four metabolic risk factors respectively). However, among women, clear associations were not observed between sFas levels and the four metabolic risk factors or their clustering. Conclusions Serum sFas levels appear to be associated with overweight/obesity, hyperlipidaemia and clusters of metabolic risk factors among men, suggesting that sFas may elevate to down-regulate increased apoptosis in atherogenesis processes.",
author = "Akiko Tamakoshi and Koji Suzuki and Yingsong Lin and Yoshinori Ito and Kiyoko Yagyu and Shogo Kikuchi and Yoshiyuki Watanabe and Yutaka Inaba and Kazuo Tajima and Kei Nakachi",
year = "2010",
month = "6",
day = "1",
doi = "10.1111/j.1365-2362.2010.02293.x",
language = "English",
volume = "40",
pages = "527--533",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Wiley-Blackwell",
number = "6",

}

Tamakoshi, A, Suzuki, K, Lin, Y, Ito, Y, Yagyu, K, Kikuchi, S, Watanabe, Y, Inaba, Y, Tajima, K & Nakachi, K 2010, 'Relationship of sFas with metabolic risk factors and their clusters', European Journal of Clinical Investigation, vol. 40, no. 6, pp. 527-533. https://doi.org/10.1111/j.1365-2362.2010.02293.x

Relationship of sFas with metabolic risk factors and their clusters. / Tamakoshi, Akiko; Suzuki, Koji; Lin, Yingsong; Ito, Yoshinori; Yagyu, Kiyoko; Kikuchi, Shogo; Watanabe, Yoshiyuki; Inaba, Yutaka; Tajima, Kazuo; Nakachi, Kei.

In: European Journal of Clinical Investigation, Vol. 40, No. 6, 01.06.2010, p. 527-533.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relationship of sFas with metabolic risk factors and their clusters

AU - Tamakoshi, Akiko

AU - Suzuki, Koji

AU - Lin, Yingsong

AU - Ito, Yoshinori

AU - Yagyu, Kiyoko

AU - Kikuchi, Shogo

AU - Watanabe, Yoshiyuki

AU - Inaba, Yutaka

AU - Tajima, Kazuo

AU - Nakachi, Kei

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Background: Metabolic risk factors are known to cause atherosclerosis through inflammation. In the process of inflammation, soluble Fas (sFas) may interfere with the apoptotic pathway and contribute to dysregulated inflammation. Recent studies suggest sFas as a marker of inflammation in patients with cardiovascular diseases. However, whether a relationship exists between sFas levels and metabolic risk factors among healthy subjects remains unclear. Materials and methods We measured the serum sFas levels of 876 subjects selected as controls for a nested case-control study within the JACC Study. The adjusted means of the sFas levels were compared according to the presence of overweight/obesity, hypertension, hyperlipidaemia, diabetes and their clusters. Results sFas level was significantly associated with overweight/obesity (2·42 ng mL-1 in overweight/obese men and 2·19 in others) and hyperlipidaemia (2·34 ng mL-1 in men with hyperlipidaemia and 2·19 in others) among men, though not with hypertension or diabetes. Moreover, a clear association between sFas levels and the cluster number of metabolic risk factors was observed independently with age, smoking and drinking(2·39, 2·28, 2·24 and 2·11 ng dL-1 in men with three to four, two, one and none of the four metabolic risk factors respectively). However, among women, clear associations were not observed between sFas levels and the four metabolic risk factors or their clustering. Conclusions Serum sFas levels appear to be associated with overweight/obesity, hyperlipidaemia and clusters of metabolic risk factors among men, suggesting that sFas may elevate to down-regulate increased apoptosis in atherogenesis processes.

AB - Background: Metabolic risk factors are known to cause atherosclerosis through inflammation. In the process of inflammation, soluble Fas (sFas) may interfere with the apoptotic pathway and contribute to dysregulated inflammation. Recent studies suggest sFas as a marker of inflammation in patients with cardiovascular diseases. However, whether a relationship exists between sFas levels and metabolic risk factors among healthy subjects remains unclear. Materials and methods We measured the serum sFas levels of 876 subjects selected as controls for a nested case-control study within the JACC Study. The adjusted means of the sFas levels were compared according to the presence of overweight/obesity, hypertension, hyperlipidaemia, diabetes and their clusters. Results sFas level was significantly associated with overweight/obesity (2·42 ng mL-1 in overweight/obese men and 2·19 in others) and hyperlipidaemia (2·34 ng mL-1 in men with hyperlipidaemia and 2·19 in others) among men, though not with hypertension or diabetes. Moreover, a clear association between sFas levels and the cluster number of metabolic risk factors was observed independently with age, smoking and drinking(2·39, 2·28, 2·24 and 2·11 ng dL-1 in men with three to four, two, one and none of the four metabolic risk factors respectively). However, among women, clear associations were not observed between sFas levels and the four metabolic risk factors or their clustering. Conclusions Serum sFas levels appear to be associated with overweight/obesity, hyperlipidaemia and clusters of metabolic risk factors among men, suggesting that sFas may elevate to down-regulate increased apoptosis in atherogenesis processes.

UR - http://www.scopus.com/inward/record.url?scp=77952643786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952643786&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2362.2010.02293.x

DO - 10.1111/j.1365-2362.2010.02293.x

M3 - Article

C2 - 20584172

AN - SCOPUS:77952643786

VL - 40

SP - 527

EP - 533

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 6

ER -